Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 5
2020 5
2021 3
2023 2
2024 3
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.
van der Wilk BJ, Eyck BM, Wijnhoven BPL, Lagarde SM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, van Klaveren D, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO Study Group. van der Wilk BJ, et al. Lancet Oncol. 2025 Apr;26(4):425-436. doi: 10.1016/S1470-2045(25)00027-0. Epub 2025 Mar 17. Lancet Oncol. 2025. PMID: 40112851 Clinical Trial.
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Verschoor YL, van de Haar J, van den Berg JG, van Sandick JW, Kodach LL, van Dieren JM, Balduzzi S, Grootscholten C, IJsselsteijn ME, Veenhof AAFA, Hartemink KJ, Vollebergh MA, Jurdi A, Sharma S, Spickard E, Owers EC, Bartels-Rutten A, den Hartog P, de Miranda NFCC, van Leerdam ME, Haanen JBAG, Schumacher TN, Voest EE, Chalabi M. Verschoor YL, et al. Among authors: bartels rutten a. Nat Med. 2024 Feb;30(2):519-530. doi: 10.1038/s41591-023-02758-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191613 Free PMC article. Clinical Trial.
Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy.
Beekman MJ, Terra L, Heemskerk-Gerritsen BAM, van der Aalst CM, Roeters van Lennep JE, van Beurden M, van Doorn HC, de Hullu JA, van Dorst EBL, Mom CH, Mourits MJE, Slangen BFM, Bartels-Rutten A, Budde RPJ, Snoeren MM, Leiner T, de Jong PA, Vliegenthart R, Planken RN, Mihl C, Vonder M, Oudkerk M, Gaarenstroom KN, Gratama JWC, van Engelen K, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, Berger LPV, Gomez Garcia EB, van Asperen CJ, Hooning MJ, de Koning HJ, Maas AHEM, van Leeuwen FE. Beekman MJ, et al. Among authors: bartels rutten a. JACC CardioOncol. 2024 Nov 19;6(6):922-931. doi: 10.1016/j.jaccao.2024.09.011. eCollection 2024 Dec. JACC CardioOncol. 2024. PMID: 39801648 Free PMC article.
Motion-compensated FDG PET/CT for oesophageal cancer.
Voncken FEM, Vegt E, van Sandick JW, van Dieren JM, Grootscholten C, Bartels-Rutten A, Takken SL, Sonke JJ, van de Kamer JB, Aleman BMP. Voncken FEM, et al. Among authors: bartels rutten a. Strahlenther Onkol. 2021 Sep;197(9):791-801. doi: 10.1007/s00066-021-01761-w. Epub 2021 Apr 7. Strahlenther Onkol. 2021. PMID: 33825916
Is the generalizability of a developed artificial intelligence algorithm for COVID-19 on chest CT sufficient for clinical use? Results from the International Consortium for COVID-19 Imaging AI (ICOVAI).
Topff L, Groot Lipman KBW, Guffens F, Wittenberg R, Bartels-Rutten A, van Veenendaal G, Hess M, Lamerigts K, Wakkie J, Ranschaert E, Trebeschi S, Visser JJ, Beets-Tan RGH; ICOVAI, International Consortium for COVID-19 Imaging AI. Topff L, et al. Among authors: bartels rutten a. Eur Radiol. 2023 Jun;33(6):4249-4258. doi: 10.1007/s00330-022-09303-3. Epub 2023 Jan 18. Eur Radiol. 2023. PMID: 36651954 Free PMC article.
Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approach.
Ten Haaft BHEA, van Kessel E, van Berge Henegouwen MI, van den Bergh JE, Bolhuis K, Dohmen SE, Erdmann JI, van Geel AM, Gerhards MF, Gorris M, Kager LM, Kodach LL, Kok NFM, Koorstra JM, Laeijendecker AE, van Sandick JW, Schreurs WH, Sommeijer DW, Swijnenburg RJ, Tuynman JB, Verheij J, Versteijne E, van der Velden AMT, Voncken FEM, Wientjes CA, Wilmink JW, Zonderhuis BM, Kazemier G, Besselink MG; OncoNoVo+ regional oncology network. Ten Haaft BHEA, et al. BMC Cancer. 2025 Aug 30;25(1):1402. doi: 10.1186/s12885-025-14710-y. BMC Cancer. 2025. PMID: 40885947 Free PMC article.
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
Noordman BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, Coene PPLO, Dekker JWT, Doukas M, van der Gaast A, Heisterkamp J, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JEN, Rosman C, van Sandick JW, van der Sangen MJC, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO-study group. Noordman BJ, et al. BMC Cancer. 2018 Feb 6;18(1):142. doi: 10.1186/s12885-018-4034-1. BMC Cancer. 2018. PMID: 29409469 Free PMC article.
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Verschoor YL, van de Haar J, van den Berg JG, van Sandick JW, Kodach LL, van Dieren JM, Balduzzi S, Grootscholten C, IJsselsteijn ME, Veenhof AAFA, Hartemink KJ, Vollebergh MA, Jurdi A, Sharma S, Spickard E, Owers EC, Bartels-Rutten A, den Hartog P, de Miranda NFCC, van Leerdam ME, Haanen JBAG, Schumacher TN, Voest EE, Chalabi M. Verschoor YL, et al. Among authors: bartels rutten a. Nat Med. 2024 May;30(5):1499. doi: 10.1038/s41591-024-02898-8. Nat Med. 2024. PMID: 38448792 Free PMC article. No abstract available.
Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHMW, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ; PRIDE study group. Borggreve AS, et al. Among authors: bartels rutten a. BMC Cancer. 2018 Oct 20;18(1):1006. doi: 10.1186/s12885-018-4892-6. BMC Cancer. 2018. PMID: 30342494 Free PMC article.
22 results